Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

The key is the ligand — that’s the general word for whatever chemical messenger or signaling molecule attaches to the receptor, activating it. For GLP-1 receptors, it’s GLP-1. Ozempic ...

(Trinidad Express) The drug Ozempic is not registered for sale in Trinidad and Tobago, says secretary/treasurer of the Pharmacy Board of Trinidad and Tobago, Sanjay Mohammed. He made the ...

Glutathione has been nicknamed the "master antioxidant," but some people are buying it online and self-injecting it, which ...

He said that, in some instances, they have seen people selling this molecule or this fake Ozempic and it could actually be insulin, and insulin may cause them to lower their blood sugar quickly ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of ...

With the recent surge in popularity of weight loss drugs like Ozempic, altogether called GLP-1s, there has been renewed scientific interest in understanding how our bodies regulate muscle growth.

Novo expects to continue to grow its reach in 2025, though perhaps not at the magnitude witnessed in 2024. For the full year to come, Novo Nordisk is eyeing sales growth at constant currencies between ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...